Filter posts

NCATS R&D Day Aimed At Linking Investors to Preclinical Drug Development Projects

On behalf of the National Center for Advancing Translational Sciences (NCATS), I invite BIO stakeholders …

New FDA Final Guidance on Clinical Trial Institutional Review Boards

On Tuesday, August 27th, the FDA finalized its Guidance for Institutional Review Boards, Clinical Investigators …

The Dangers of Being Misinformed: Latest Measles Outbreak

USA Today covered the latest measles outbreak in today’s print edition (see story: Texas Measles …

Involving Patients in the Research Process

According to the National Psoriasis Foundation, as many as 7.5 million Americans live with psoriasis, …

GAINing Ground in Antibiotics

With the rise of antibiotic resistant “superbugs” in recent years, everyone agrees there is an …

FDA Issues Final Guidance on Clinical Trial Oversight

The FDA released its final guidance governing clinical trial oversight and urges a risk-based approach …

Back to School: Time for Immunization Check-In

Preparing for school means gathering supplies and backpacks. It is also the perfect time to …

How the Orphan Drug Tax Credit Leverages MDA’s Fight against Rare Genetic Diseases

In the early 1950s, a small group of concerned parents, people with muscular dystrophy and …

Amid Doping Scandals, Industry Must Remain Vigilant

As doping in sport makes its way back into the news of the day, we …

How Do Patients Get Their Medicines During Hurricanes?

Hurricane season has grown to last six months – running June through November. This means …